期刊文献+

维持性血液透析患者hs-CRP和IL-6与心脏结构功能变化的临床观察 被引量:5

Clinical observation of high sensitivity C-reactive protein and interleukin-6 in relation to changes of cardiac structure and function in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨维持性血液透析(MHD)患者微炎症状态和心脏结构、功能变化的关系。方法选择徐州医学院第二附属医院血液净化中心维持性血液透析患者共48例,同时设立健康对照组,测定空腹血清中超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)浓度值,通过彩色多谱勒测定患者的心脏结构和功能。结果维持性血液透析组hs-CRP、IL-6、左心室内径(LVD)、左心房内径(LAD)、室间隔厚度(IVST)、左心室后壁厚度(LVPWT)水平均显著高于正常对照组(P<0.01),有统计学意义,而2组的左心室射血分数(EF)、E/A的值间差异无统计学意义(P>0.05);血液透析患者hs-CRP、IL-6与LAD、LVD、IVST、LVPWT呈正相关,有80%患者存在舒张功能障碍。结论MHD患者的hs-CRP、IL-6变化与其心脏结构变化有一定相关性。 Objective To investigate the relationship between microinflammation and changes of cardiac structure and function in maintenance hemodialysis (NHD) patients. Methods We recruited 48 patients on mainte-nance hemodialysis in this blood purification center, and 20 normal individuals as the controls. Serum high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6) were measured. Cardiac structure and function were evaluated by ultrasonic cardiography. Results Serum hs-CRP, IL-6, left ventricular dimension (LVD), left atrial dimension (LAD), interventricular septum thickness (IVST) and left ventricular dimension posterior wall thickness (LVPWT) were sig-nificantly higher in MHD patients than in controls (P〈0.01). Serum hs-CRP and IL-6 were positively correlated with the values of LAD, LVD, IVST and LVPWT in MHD patients. Doppler echocardiology showed that 80% of the MHD patients had heart diastolic dysfunction. Conclusion MHD patients had higher serum hs-CRP and IL-6, which may correlate with the changes of cardiac structures.
出处 《中国血液净化》 2008年第2期69-70,共2页 Chinese Journal of Blood Purification
关键词 维持性血液透析 超敏C-反应蛋白 白介素-6 心脏功能 心脏结构 Maintenance hemodialysis High-sensitivity C-reactive protein (Hs-CRP) Interleukin-6 (IL-6) Cardiac structure Cardiac function
  • 相关文献

参考文献5

二级参考文献14

  • 1[1]Levey AS,Beto JA,Coronado BE et al.Controlling the epidemic of cardiovascular disease in chronic renal disease:What do we know? What do we learn? Where do we go from here? Am J Kidney Dis,1998,32:853
  • 2[2]Cohen GI, Pietrolungo JF, Thomas JD et al. A practical guide to assessment of ventricular diastolic function using doppler echocardiogram. JACC,1996,27:1753
  • 3[3]Sachs RN,Valensi P, Lormeau B et al.Determinants of echocardiographically measured LVM in diabetic patients with or without silent myocardial ischaemia. Diabetes Metab,1999 Jun,25(2):128
  • 4[4]Robert NF, Patrick SP, Mark JS.Cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998,32(5) Suppl 3:112
  • 5[5]Parfrey PS,Harnett JD, Griffiths SM et al.The clinical course of left ventricular hypertrophy in dialysis patients. Nephron,1990,55:114
  • 6[6]Dahan M, Sichan P,Viron B et al. Relationship between left ventricular hypertrophy: myocardial contractility; and load conditions in hemodialysis patients; an echocardiographic study. Am J Kidney Dis,1997,30:780
  • 7[7]Harnett JD, Murphy B, Collingwood P et al.The reliability and validity of echocardiographic measurement of left ventricular mass in hemodialysis patents. Nephron,1993,65:212
  • 8[8]Wizemann V, Schafer R, Kramer W et al.Follow up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left ventricular hypertrophy. Nephron,1993,64(2):202
  • 9[9]Pai RG,Buech GC. Newer Doppler measurements of left ventricular diastolic function. Clin Cadiol,1996,(19):277
  • 10[10]Levy D, Garrison RJ, Savage DD et al.Prognostic implications of echocardiographic determined left ventricular mass in the Framinghan Heart Study. N Eng1 J Med,1990,322:1561

共引文献24

同被引文献34

  • 1王梅.老年人终末期肾病的血液透析治疗及并发症的处理[J].中华老年医学杂志,2006,25(1):23-24. 被引量:33
  • 2Dhar S,Pressman GS,Subramanian S,et al.Natriuretic peptides and heart failure in the patient with chronic kidney disease:a review of current evidence[J].Postgrad Med J,2009,85:299-302.
  • 3McIntyre CW.Effects of hemodialysis on cardiac function[J].Kidney Int,2009,76:371-375.
  • 4Wang AY,Lam CW,Wang M,et al.Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients[J].Nephrol Dial Transplant,2009,24:1962-1969.
  • 5Zumrutdal A,Sezer S,Demircan S,et al.Cardiac troponin Ⅰ and beta 2 microglobulin as risk factors for early-onset alherosclerosis in patients on haemodialysis[J].Nephrology(Carlton),2005,10:453-458.
  • 6Coen G,Mantella D,Sardella D,et al.Asymmetric dimethylarginine,vascular calcifications and parathyroid hormone serum levels in bemodialysis patients[J].J Nephrol,2009,22:616-622.
  • 7Mclntyre CW. Effects of hemodialysis on cardiac function. Kidney Int, 2009,76 : 371-375.
  • 8Ana de Lurdes ACV, Alexandre B, Anabela M, et al. Homocysteine is a risk factor in predialysis patients when associated with malnutrition and inflammation. Int J Nephrol, 2010,4: 4061-4064.
  • 9彭益,陈作友.尿毒症患者血液透析对红细胞免疫功能与脂质过氧化关系的研究[J].中国健康月刊:学术版,2010,29(7):30-32.
  • 10Buscher AK, Buscher R, Hauffa BP,et al. Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney dis- ease [J]. Pediatric Nephrology, 2010, 25 (11) : 2295- 2301.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部